BRIEF published on 03/26/2025 at 22:10, 1 year 5 months ago Abivax publishes its 2024 financial reports Biotechnology AMF Abivax Financial Reports DRY
PRESS RELEASE published on 03/26/2025 at 22:05, 1 year 5 months ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax publie ses rapports financiers annuels pour l'année 2024 auprès des autorités de régulation des marchés financiers en France et aux États-Unis Autorité Des Marchés Financiers Biotechnologie Abivax Securities And Exchange Commission Rapports Financiers
PRESS RELEASE published on 03/26/2025 at 22:05, 1 year 5 months ago Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax publie ses rapports financiers auprès des autorités françaises et américaines de régulation des marchés financiers Abivax Marchés Financiers Rapports Financiers Autorités Françaises Autorités Américaines
PRESS RELEASE published on 03/26/2025 at 22:05, 1 year 5 months ago Abivax publishes financial reports with the French and U.S. securities regulatory agencies Abivax publishes financial reports with French and U.S. securities regulatory agencies. The company filed its Universal Registration Document and Annual Report for 2024 Abivax Financial Reports Regulatory Agencies U.S. Securities French
BRIEF published on 03/24/2025 at 08:35, 1 year 5 months ago Abivax Publie ses Résultats Financiers pour 2024 Résultats Financiers Biotechnologie Recherche Et Développement Trésorerie Essais Cliniques
BRIEF published on 03/24/2025 at 08:35, 1 year 5 months ago Abivax Publishes its Financial Results for 2024 Financial Results Biotechnology Research And Development Treasury Clinical Trials
PRESS RELEASE published on 03/24/2025 at 08:30, 1 year 5 months ago Abivax Annonce ses Résultats Financiers pour l’Exercice 2024 Abivax annonce ses résultats financiers pour l’exercice 2024. Trésorerie de 144,2 millions d’euros au 31 décembre 2024. Perspectives financières disciplinées Résultats Financiers Biotechnologie Abivax Trésorerie Perspectives Financières
PRESS RELEASE published on 03/24/2025 at 08:30, 1 year 5 months ago Abivax Announces Full Year 2024 Financial Results Abivax announces full year 2024 financial results, cash balance of EUR 144.2M, ABTECT trial progress. CEO optimistic about 2025 milestones and financial outlook Financial Results Cash Position Abivax ABTECT Trial Clinical Progress
PRESS RELEASE published on 03/24/2025 at 08:30, 1 year 5 months ago Abivax Annonce ses Résultats Financiers pour l’Exercice 2024 Abivax annonce ses résultats financiers annuels pour l'Exercice 2024, montrant une trésorerie de 144,2 millions d'euros finançant les activités jusqu'au T4 2025, avec des résultats top-line attendus au T3 2025 Résultats Financiers Abivax Trésorerie Rectocolite Hémorragique Phase 3 ABTECT
BRIEF published on 03/14/2025 at 15:21, 1 year 6 months ago JP Morgan Chase réduit sa participation dans ABIVAX Franchissement De Seuil Actions Abivax Réglementation JP Morgan Chase
Published on 09/22/2026 at 17:00, 1 hour 46 minutes ago Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 16:30, 2 hours 16 minutes ago Formation Metals Intersects 0.98 g/t Au over 95.6 Metres Starting 7 Metres Below Surface, Including 3.14 g/t Au over the First 10 Metres, Extending the A-Zone Up to 50 Metres North at N2
Published on 09/22/2026 at 15:25, 3 hours 21 minutes ago Aztec Minerals Announces Closing of Upsized C$6.4 Million Bought Deal Private Placement Including Concurrent Exercise of Underwriter's Option
Published on 09/22/2026 at 15:20, 3 hours 26 minutes ago MicroVision Introduces Advanced Photonics Technology for Next-Generation AI Data Center Scale-Up Architecture
Published on 09/22/2026 at 18:30, 16 minutes ago Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 18:30, 16 minutes ago Voyageurs du Monde: Communiqué sur le dépôt de projet de note en réponse (suite au dépôt de projet de note en réponse de Voyageurs du Monde à l'Autorité des Marchés Financiers)
Published on 09/22/2026 at 18:30, 16 minutes ago IEVA GROUP: Visioconférence actionnaires et investisseurs Jeudi 15 octobre 2026 - 18h00 (CEST)
Published on 09/22/2026 at 17:45, 1 hour 1 minute ago Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Published on 09/22/2026 at 17:45, 1 hour 1 minute ago Carvolix dépose le dossier 510(k) pour le robot TAVIPILOT et progresse vers le lancement commercial de sa plateforme TAVIPILOT aux États-Unis.
Published on 09/22/2026 at 18:00, 46 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 18:00, 46 minutes ago Résultats consolidés du premier semestre 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 1 hour 1 minute ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/22/2026 at 17:45, 1 hour 1 minute ago Imerys-09-2026-communique-capital-droits-de-vote-au-31-août-2026
